National Pharmacy Health & Leadership Alliance Verify a MemberMember Login

NPHLA Daily

NPHLA Daily

Thursday, November 19, 2026 · 4-minute read

Good morning. Here is what changed across metabolic medicine, pharmacy regulation, aesthetics and healthcare technology since yesterday — every item linked to its source.

What changed today in Metabolic: 8 trial updates, 1 new study

NPHLA tracked 9 new official records on this desk today: 8 trial updates, 1 new study. First: New trial registered: A Clinical Trial to Evaluate the Effects of Glow Shakes Premium Collagen Meal Replacement on Nutritional Adequacy, Body Composition, Skin Health,…

Trial status changed to “Recruiting”: SYNCHRONIZE®-START- A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight

Phase 3, Boehringer Ingelheim. Previously “Not yet recruiting”. Conditions: Obesity. Interventions: Survodutide. Investigational: trial-stage therapies are not approved for the use studied.

What changed today in Regulatory: 1 recall record

NPHLA tracked 1 new official record on this desk today: 1 recall record. First: Recall: Fresh & Ready Foods LLC Expands Recall to Include Fresh to You Brand Sausage, Egg & Cheese Biscuit Sandwich and Meals Made in Minutes… — reason given: not stated (firm: not stated).

What changed today in Aesthetics & Longevity: 1 new study

NPHLA tracked 1 new official record on this desk today: 1 new study. First: New research in Cureus: “Human Adipose Tissue Allograft for Facial and Body Volume Loss Shows Favorable Safety and Aesthetic Outcomes”.

Comments close: Compounding Animal Drugs From Bulk Drug Substances: Compounding Under CGMP in Federally-Registered Facilities; Draft Guidance for Industry; Availability; Agency Information…

November 26, 2026 — verified from the Federal Register comments_close_on.

5 things to know

  1. What changed today in Metabolic: 8 trial updates, 1 new study
  2. What changed today in Aesthetics & Longevity: 1 new study
  3. What changed today in Regulatory: 1 recall record
  4. Trial status changed to “Recruiting”: SYNCHRONIZE®-START- A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight (ClinicalTrials.gov (U.S. National…
  5. Trial status changed to “Recruiting”: SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished… (ClinicalTrials.gov (U.S.…

Compiled by NPHLA Intelligence from published briefings and official records. Professional information only — not medical or legal advice. Our standards.